Claims for Patent: 7,939,323

Summary for Patent: 7,939,323

Title:	Method of isolating cells from umbilical cord
Abstract:	The present invention relates a method for isolating four cell types from a single umbilical cord as pure cultures. These cell lines (epithelial cells, fibroblasts, smooth muscle cells and endothelial cells) can be characterized and utilized in experimental models and for therapeutic purposes. Particularly, the umbilical cells isolated herein are used to form a tissue replacement or engineered living composition. Also, the isolated umbilical cells of the invention may have the potential of progenitor cells.
Inventor(s):	Auger; Francois A. (Quebec, CA), Germain; Lucie (Saint-Augustin, CA), Remy-Zolghadri; Murielle (Le Bouscat, FR), Hayward; Cindy J. (Sainte-Roy, CA)
Assignee:	Universite Laval (Quebec, CA)
Application Number:	11/924,661
Patent Claims:	1. A method for the simultaneous isolation of four cell types from one umbilical cord sample comprising the subsequent steps of: a) isolating endothelial cells by perfusing a vein from a section of said umbilical cord with a solution comprising thermolysin for a period of time to allow detachment of said endothelial cells from said vein; b) treating the section of said umbilical cord of step a) with a solution of trypsin-EDTA for a time sufficient to allow detachment and isolation of epithelial cells; c) mechanically removing smooth muscle cells and fibroblast-like cells from the section of said umbilical cord of step b) substantially devoid of endothelial and epithelial cells, followed by a culture period of sufficient time to allow separation and isolation of smooth muscle and fibroblast-like cells from laminae; and d) harvesting the isolated cells of steps a) to c). 2. The method of claim 1, wherein said cell types are progenitor cells. 3. A method for the simultaneous isolation of four cell types from one umbilical cord sample comprising the subsequent steps of: a) isolating endothelial cells by perfusing a vein from a section of said umbilical cord with a solution comprising at least one of thermolysin or collagenase for a period of time to allow detachment of said endothelial cells from said vein; b) allowing the digestion of smooth muscle cells from a ring-shaped media surrounding the vein of the umbilical cord of step a) through a second perfusion with a solution comprising collagenase for a time sufficient to allow detachment of smooth muscle cells from said vein; c) isolating epithelial cells by treating a section of said umbilical cord with a solution comprising trypsin-EDTA for a time sufficient to allow detachment of said epithelial cells; and d) isolating fibroblast like-cells by culturing a sample of a Warton's jelly layer taken from the exterior of a section of said umbilical cord in a solution comprising collagenase for a period of time sufficient to allow separation and isolation of fibroblast-like cells from said the Warton's jelly layer; and e) harvesting isolated cells of steps a) to d). 4. A method for the simultaneous isolation of four cell types from one umbilical cord sample comprising the subsequent steps of: a) isolating epithelial cells by treating a section of said umbilical cord in a solution comprising trypsin-EDTA for a time sufficient to allow detachment of said epithelial cells; b) mechanically removing endothelial cells from the inner surface of an umbilical cord vein of said umbilical cord sample; c) mechanically removing smooth muscle cells from the section of step b) substantially devoid of endothelial cells, and d) mechanically removing fibroblast-like cells from the section of step c) substantially devoid of smooth muscle cells followed by a culture period of sufficient time to allow separation and isolation of smooth muscle and fibroblast-like cells from laminae; and e) harvesting the isolated cells of steps a) to e). 5. The method of claim 4, wherein said removing of step b) is performed by scraping said umbilical cord vein. 6. The method of claim 4, wherein said cell types are progenitor cells. 7. The method of claim 3, wherein said cell types are progenitor cells.

Details for Patent 7,939,323

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2023-06-27